Pat Cotroneo
No más puestos en curso
Perfil
En la actualidad, Pat Cotroneo es Director Financiero y Vicepresidente Senior de Finanzas de FibroGen, Inc. El Sr. Cotroneo ocupó anteriormente el cargo de interventor de Systemix, Inc. y de interventor de Genetic Therapy, Inc. Se licenció en la Universidad de San Francisco.
Antiguos cargos conocidos de Pat Cotroneo.
| Empresas | Cargo | Fin |
|---|---|---|
| FIBROGEN, INC. | Director of Finance/CFO | 07/09/2021 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Comptroller/Controller/Auditor | 01/01/2000 |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Comptroller/Controller/Auditor | 01/01/2000 |
Formación de Pat Cotroneo.
| University of San Francisco | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Bolsa de valores
- Insiders
- Pat Cotroneo
